148 results on '"Kirkegaard, Thomas"'
Search Results
2. Efficacy and safety of arimoclomol in Niemann‐Pick disease type C: Results from a double‐blind, randomised, placebo‐controlled, multinational phase 2/3 trial of a novel treatment
3. Prenatal affective cognitive training: A proof-of-concept study
4. "Uden indre Logik": Organicisme, Neo-Riemannian Theory og Hilda Sehesteds Sange
5. Conformational dynamics of free and membrane-bound human Hsp70 in model cytosolic and endo-lysosomal environments
6. Correction to: Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study
7. Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study
8. Differences in clinical presentation between bipolar I and II disorders in the early stages of bipolar disorder: A naturalistic study
9. Data from Sunitinib and SU11652 Inhibit Acid Sphingomyelinase, Destabilize Lysosomes, and Inhibit Multidrug Resistance
10. Supplementary Figures 1-4 from Sunitinib and SU11652 Inhibit Acid Sphingomyelinase, Destabilize Lysosomes, and Inhibit Multidrug Resistance
11. Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study
12. Heat shock protein amplification improves cerebellar myelination in the Npc1nih mouse model
13. Galactosyl- and glucosylsphingosine induce lysosomal membrane permeabilization and cell death in cancer cells
14. Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trials
15. Transformation-Associated Changes in Sphingolipid Metabolism Sensitize Cells to Lysosomal Cell Death Induced by Inhibitors of Acid Sphingomyelinase
16. Tekla Griebel Wandall (Den Store Danske)
17. Tekla Griebel Wandall:1866-1940
18. Galactosyl- and glucosylsphingosine induce lysosomal membrane permeabilization and cell death in cancer cells
19. Kirkegaard, Thomas Husted
20. Exhibiting the Unheard(-of):Cultural Memory, Cultural Oblivion, and Women Composers
21. Schenker (not) in Scandinavia
22. Introduction: European Music Analysis and the Politics of Identity
23. Arimoclomol increases the transcription of lysosomal genes, including and , to facilitate lysosomal function
24. Persistent effect of arimoclomol in patients with Niemann-Pick disease type C: 24-month results from an open-label extension of a pivotal phase 2/3 study
25. Arimoclomol reduces levels of biomarkers of lipid burden in patients with Niemann-Pick disease type C
26. Persistent Effect of Arimoclomol in Patients with Niemann-Pick Disease Type C: 24-Month Results from an Open-Label Extension of a Pivotal Phase 2/3 Study
27. Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology
28. Persistent effect of arimoclomol in patients with Nuemann-Pick disease type C: 12-month results from an open-label extension of a pivotal phase 2/3 study
29. Rescue of NPC1 protein by the heat shock response amplifier arimoclomol across multiple genotypes
30. HSP70 induces liver X receptor pathway activation and cholesterol reduction in vitro and in vivo
31. Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study
32. Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls:a longitudinal case-control study
33. Additional file 1: of Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trials
34. Animal models for Niemann-Pick type C: implications for drug discovery & development
35. The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase
36. Arimoclomol as a potential therapy for neuronopathic Gaucher Disease
37. Arimoclomol, a clinical candidate for neuronopathic Gaucher disease, increases glucocerebrosidase activity through amplification of heat shock proteins
38. Differences in clinical presentation between bipolar I and II disorders in the early stages of bipolar disorder:A naturalistic study
39. Heat shock protein-based therapy for sphingolipidoses
40. Heat shock protein–based therapy as a potential candidate for treating the sphingolipidoses
41. Development of heat shock protein based therapies for lysosomal diseases
42. Accuracy of abdominal auscultation for bowel obstruction
43. Effects of a screening and treatment protocol with haloperidol on post-cardiotomy delirium:a prospective cohort study
44. Lysosomal storage diseases and the heat shock response: convergences and therapeutic opportunities
45. Corrigendum to “Activation of phospholipase A2 by Hsp70 in vitro” [Biochim. Biophys. Acta 1808 (2011) 2569–2572]
46. Human heat shock protein 70 (Hsp70) as a peripheral membrane protein
47. Lysosomal Stability Assay
48. Identification of Autophagosome-associated Proteins and Regulators by Quantitative Proteomic Analysis and Genetic Screens
49. Identification of autophagosome-associated proteins and regulators by quantitative proteomic analysis and genetic screens
50. Activation of phospholipase A2 by Hsp70 in vitro
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.